Close Menu

This article has been updated with additional information from Bionano's earnings call.

NEW YORK (GenomeWeb) – Bionano Genomics reported after the close of the market on Thursday a 41 percent year-over-year increase in its fourth quarter revenues, the company's first full quarter as a publicly traded firm.

Separately, the firm said it has entered into two separate debt and equity financing agreements totaling $41.5 million with Innovatus Life Sciences Lending Fund, East West Bank, and Aspire Capital.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.